~~<i id='C79947C550'><strike id='C79947C550'><tt id='C79947C550'><pre id='C79947C550'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

Wikipedia

author：fashion 2025-10-03 00:03:40 - browse：5

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Eli Lilly said Tuesday that it will purchase DICE Therapeutics, a small company developing an experimental pill to treat psoriasis, for $2.4 billion in cash.

The deal price of $48 per share represents a 42% premium to DICE’s closing price Friday.

“In combination with its novel technology and expertise in drug discovery, DICE’s talented workforce and passion for innovation will enhance our efforts to make life better for people living with devastating autoimmune diseases,” Patrik Jonsson, executive vice president, president of Lilly Immunology and Lilly USA, chief customer officer, said in a statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Drugmakers bet big on mRNA for cancer. Why's Biden going in?

knowledge

focus

explore

hotspot

leisure time

AchildreceivesaCovid-19vaccinationinNeedham,Mass.JOSEPHPREZIOSO/AFPviaGettyImagesWithlastfall’schaot

WSS

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Vivek Ramaswamy made waves in the debate, much as in biotech

How to make over

Wegovy improves function in certain heart failure patients

Wegovy improves function in certain heart failure patients

Study: Spinal cord stimulation helps patients with paralysis walk again

leisure time

Wikipedia

knowledge

The high cost of giving birth even with insurance

Kellogg’s is going to war over Mexico’s nutrition label rules

23andMe had bad news about my health. I wish a person had delivered it

Vivek Ramaswamy made waves in the debate, much as in biotech

BioMarin wins approval for gene therapy to treat hemophilia A

FDA greenlights medical device to combat bladder issues

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

PBMs are inflating the cost of generic drugs. They must be reined in

State Dept. review finds Biden bears some blame for Afghanistan failures

Study: Spinal cord stimulation helps patients with paralysis walk again

focus

How to make over

Republicans love RFK Jr. What's that tell us about health in 2024?

Intellia plays down concerns on accidental germline transmission

Intellia plays down concerns on accidental germline transmission

Vivek Ramaswamy made waves in the debate, much as in biotech

Trans patients at the end of life deserve respect and dignity

focus

explore

hotspot

leisure time